Why Invest

We develop products and solutions that make life better – and have been successfully doing so for over 300 years. And when you’ve prospered for centuries as we have, you must have done a few things right.

It’s a great idea to invest in us – and here’s why

Related News

View All News
  1. Press Releases

    Merck KGaA, Darmstadt, Germany, Collaborates with Acceleration Consortium on ...

    AI-driven experimentation planner BayBE (Bayesian Back End) by us and Acceleration Consortium is available open-source on GitHub

    2023/12/06

  2. Press Releases

    MilliporeSigma Launches First Ever AI Solution to Integrate Drug Discovery ...

    AIDDISON™ software-as-a-service platform bridges the gap between virtual molecule design and real-world manufacturing.

    2023/12/05

  3. Press Releases

    Merck KGaA, Darmstadt, Germany Provides Update on Phase III Results for Evobrutinib ...

    Two Phase III EVOLUTION clinical trials of evobrutinib did not meet their primary endpoints.

    2023/12/05

investors-shareprice2 investors-shareprice2
Share Price
Check Share Price
Share Price
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
453077651 453077651
Financials
Read More
Financials
Our Financial Reporting Center offers you the opportunity to select from financial data on an annual or quarterly basis.